ストックスクリーナーアプリを入手
8.15
5.65%
-0.70
前日終値:
$8.85
開ける：
$8.8
24時間の取引高:
362.53K
Relative Volume:
0.09
時価総額：
$93.21M
収益：
-
当期純損益:
$-6.42M
株価収益率:
-1.455
EPS:
-5.6013
ネットキャッシュフロー:
$-7.45M
1週間 パフォーマンス:
-10.89%
1か月 パフォーマンス:
+276.98%
6か月 パフォーマンス:
-45.46%
1年 パフォーマンス:
-59.84%
1日の値動き範囲:
$8.01
$8.899
1週間の範囲:
$8.18
$16.94
52週間の値動き範囲:
$1.80
$25.92
Cervomed Inc Stock (CRVO) Company Profile
CRVO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CRVO
Cervomed Inc
|
8.10 | 93.21M | 0 | -6.42M | -7.45M | -5.6013 |
|
VRTX
Vertex Pharmaceuticals Inc
|
503.52 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
641.90 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
588.05 | 35.74B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
271.70 | 35.58B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
249.85 | 27.23B | 3.81B | -644.79M | -669.77M | -6.24 |
Cervomed Inc Stock (CRVO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-13 | アップグレード | Chardan Capital Markets | Neutral → Buy |
| 2024-12-17 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2024-12-11 | ダウングレード | Chardan Capital Markets | Buy → Neutral |
| 2024-12-11 | ダウングレード | Morgan Stanley | Overweight → Underweight |
| 2024-12-10 | ダウングレード | D. Boral Capital | Buy → Hold |
| 2024-12-06 | 開始されました | ROTH MKM | Buy |
| 2024-12-05 | 開始されました | H.C. Wainwright | Buy |
| 2024-09-18 | 開始されました | Chardan Capital Markets | Buy |
| 2024-07-26 | 開始されました | Morgan Stanley | Overweight |
| 2024-02-15 | 開始されました | Canaccord Genuity | Buy |
| 2020-11-17 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2018-03-21 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Cervomed Inc (CRVO) 最新ニュース
CervoMed Announces Oral Presentation at 19th International - GlobeNewswire
CervoMed Inc. to Present Findings on Neflamapimod in Dementia with Lewy Bodies at AP/PD™ Conference 2025 - Nasdaq
New Clinical Data: CervoMed's Breakthrough Dementia Drug Results Revealed at Global Conference - StockTitan
CervoMed: Extension Study Data In Dementia With Lewy Bodies Is Potentially Exciting, With Caveats - Seeking Alpha
CervoMed Stock: Extension Study Data In Dementia Is Potentially Exciting, With Caveats - Seeking Alpha
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Roth Capital Issues Negative Forecast for CervoMed Earnings - Defense World
Q1 Earnings Forecast for CervoMed Issued By Roth Capital - Defense World
Is CervoMed Inc. (CRVO) Among the Best Short Squeeze Stocks to Buy According to Analysts? - Insider Monkey
CervoMed reports FY24 EPS ($2.02), consensus ($1.85) - MSN
CervoMed Inc (CRVO) Reports Q4 Net Loss of $16.3 Million, Grant Revenue at $9.7 Million - GuruFocus.com
Roth Mkm Issues Positive Forecast for CervoMed (NASDAQ:CRVO) Stock Price - Defense World
CervoMed (NASDAQ:CRVO) Given New $21.00 Price Target at Canaccord Genuity Group - Defense World
Best Biotech Stocks To Watch Now – March 17th - Defense World
10 Best Short Squeeze Stocks to Buy According to Analysts - Insider Monkey
CervoMed price target raised to $20 from $15 at Roth MKM - TipRanks
Following A Monumental March, Can CRVO Keep The Rally Going In April? - RTTNews
CervoMed sees cash runway into mid-2026 - MSN
CervoMed Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags - Simply Wall St
CervoMed price target raised to $21 from $12 at Canaccord - TipRanks
CervoMed Inc. (CRVO): The Best Short-Term Stock to Buy Right Now - Insider Monkey
CervoMed (NASDAQ:CRVO) Given Buy Rating at D. Boral Capital - Defense World
Cervomed Inc. Faces Financial Hurdles Due to Regulatory Restrictions on Public Float - TipRanks
Small Cap Stocks To Watch NowMarch 13th - MarketBeat
Peering Into CervoMed's Recent Short Interest - Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
CervoMed Inc. Reports Earnings Results for the Full Year Ended December 31, 2024 -March 17, 2025 at 08:19 am EDT - Marketscreener.com
CervoMed Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Updates - GlobeNewswire
CervoMed's Breakthrough in Lewy Body Dementia Treatment Shows Promise in Latest Financial Report - StockTitan
Why CervoMed Inc. (CRVO) Soared Last Week? - Insider Monkey
These 10 Stocks Posted Double-, Triple-Digit Gains Last Week - Insider Monkey
Small Cap Stocks To Watch TodayMarch 12th - MarketBeat
10 Best Short-Term Stocks to Buy Now with Rebound Potential - Insider Monkey
Capital One, CervoMed, HPE, Eaton, PepsiCo: Trending by Analysts - MSN
CervoMed (CRVO) Stock: 187% Weekly Surge Catches Analysts’ Attention - MoneyCheck
CervoMed (NASDAQ:CRVO) Raised to Buy at Jones Trading - Defense World
CervoMed (NASDAQ:CRVO) Stock Rating Upgraded by Chardan Capital - Defense World
Biotech Stocks To Keep An Eye On – March 13th - Defense World
CervoMed upgraded to Buy at JonesResearch on more confidence in DLB program - Yahoo Finance
‘Turning point in dementia’—CervoMed stock skyrockets on promising dementia drug results - InvestorsObserver
We Think CervoMed (NASDAQ:CRVO) Can Afford To Drive Business Growth - Yahoo Finance
Best Biotech Stocks To Watch Now – March 12th - Defense World
CervoMed (NASDAQ:CRVO) Upgraded at Brookline Capital Management - Defense World
Medical Stocks To Keep An Eye On – March 12th - Defense World
FY2024 EPS Forecast for CervoMed Increased by Analyst - Defense World
CervoMed - The Pharma Letter
CervoMed's Dementia Study's 16-Week Data 'Compelling Enough To Move From Sidelines' Analyst Says - Benzinga India
Jones Trading lifts CervoMed stock rating, sets $15 target - Investing.com India
Trump threatens 200% tariff on European alcohol as trade war escalates - CNN
This Wells Fargo Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Benzinga
Walmart feels the heat in China after Trump imposes tariffs - CNN
Cervomed Inc (CRVO) 財務データ
収益
当期純利益
現金流量
EPS
1.66%
4.32%
大文字化:
|
ボリューム (24 時間):